{"paper_id": "1c44f40d9934b8daf891c9f9f63cc31ec94fb251", "metadata": {"title": "Prognostic value of Carcinoembryonic antigen on outcome in patients with Coronavirus disease 2019 Prognostic value of Carcinoembryonic antigen on outcome in patients with Coronavirus disease 2019", "authors": [{"first": "Jing", "middle": [], "last": "Yu", "suffix": "", "affiliation": {"laboratory": "", "institution": "Huazhong University of Science and Technology", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}, {"first": "Zhifeng", "middle": [], "last": "Yang", "suffix": "", "affiliation": {"laboratory": "", "institution": "Jinyintan Hospital", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}, {"first": "Xia", "middle": [], "last": "Zhou", "suffix": "", "affiliation": {"laboratory": "", "institution": "Jinyintan Hospital", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}, {"first": "Dongde", "middle": [], "last": "Wu", "suffix": "", "affiliation": {"laboratory": "", "institution": "Huazhong University of Science and Technology", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}, {"first": "Jian", "middle": [], "last": "Chen", "suffix": "", "affiliation": {"laboratory": "", "institution": "Huazhong University of Science and Technology", "location": {"settlement": "Wuhan", "country": "China"}}, "email": "chenjian2003@aliyun.com"}, {"first": "Ling", "middle": [], "last": "Zhang", "suffix": "", "affiliation": {"laboratory": "Key Laboratory of occupational hazard identification and control in Hubei Province", "institution": "Wuhan University of Science and Technology", "location": {"settlement": "Wuhan", "country": "China"}}, "email": "zhangling@wust.edu.cn"}, {"first": "Luqing", "middle": [], "last": "Tong", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tianjin Medical University General hospital", "location": {"settlement": "Tianjin", "country": "China"}}, "email": ""}, {"first": "Lei", "middle": [], "last": "Nie", "suffix": "", "affiliation": {"laboratory": "", "institution": "Huazhong University of Science and Technology", "location": {"settlement": "Wuhan", "country": "China"}}, "email": ""}]}, "abstract": [], "body_text": [{"text": "with CEA levels higher that 20 ng/mL had worse outcomes. The predictive ability of developed nomogram also increased when CEA was incorporated and more important than other indicators.", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "Hence, the prognostic value of initial CEA level should be under consideration as a specific marker for COVID-19 severity. Once identified, patients with high CEA levels and poor outcomes could benefit from effective treatment protocols.", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "In conclusion, the serum CEA levels were found to be increased in patients with severe or critically severe SARS-CoV-2 infection. Besides, the initial levels of CEA were associated with the prognosis of patients with COVID-19. Initial CEA levels of over 29.75 ng/mL predicted fatal outcomes in patients. Hence, our findings suggest that CEA may serve as a novel prognostic marker of COVID-19. Due to the limited follow-up time, the relationship between CEA levels and treatment effectiveness could not be explored. Therefore, studies with a higher follow-up duration are needed in the future.", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "The authors declare no conflicts of interest in this letter. ", "cite_spans": [], "ref_spans": [], "section": "Disclosure"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak", "authors": [{"first": "H", "middle": ["A"], "last": "Rothan", "suffix": ""}, {"first": "S", "middle": ["N"], "last": "Byrareddy", "suffix": ""}], "year": 2020, "venue": "Journal of autoimmunity", "volume": "109", "issn": "", "pages": "", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches", "authors": [], "year": 2018, "venue": "Recent patents on biotechnology", "volume": "12", "issn": "", "pages": "269--279", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy", "authors": [{"first": "De", "middle": [], "last": "Jong", "suffix": ""}, {"first": "C", "middle": [], "last": "Deneer", "suffix": ""}, {"first": "Vhm", "middle": [], "last": "Kelder", "suffix": ""}, {"first": "J", "middle": ["C"], "last": "", "suffix": ""}], "year": null, "venue": "Thoracic", "volume": "2020", "issn": "", "pages": "", "other_ids": {}}, "BIBREF5": {"ref_id": "b5", "title": "Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus", "authors": [], "year": 2016, "venue": "Journal of virology", "volume": "90", "issn": "", "pages": "9114--9127", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "Serum carcinoembryonic antigen: a prognostic marker in HIV-related Pneumocystis carinii pneumonia", "authors": [{"first": "J", "middle": ["P"], "last": "Bedos", "suffix": ""}, {"first": "C", "middle": [], "last": "Hignette", "suffix": ""}, {"first": "J", "middle": ["C"], "last": "Lucet", "suffix": ""}], "year": 1992, "venue": "Scandinavian journal of infectious diseases", "volume": "24", "issn": "", "pages": "309--315", "other_ids": {}}, "BIBREF7": {"ref_id": "b7", "title": "Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus", "authors": [{"first": "Z", "middle": ["M"], "last": "Chen", "suffix": ""}, {"first": "J", "middle": ["F"], "last": "Fu", "suffix": ""}, {"first": "Q", "middle": [], "last": "Shu", "suffix": ""}], "year": 2020, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF8": {"ref_id": "b8", "title": "Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19", "authors": [{"first": "R", "middle": [], "last": "Qu", "suffix": ""}, {"first": "Y", "middle": [], "last": "Ling", "suffix": ""}, {"first": "Y", "middle": ["H"], "last": "Zhang", "suffix": ""}], "year": null, "venue": "Journal of medical", "volume": "2020", "issn": "", "pages": "", "other_ids": {}}, "BIBREF9": {"ref_id": "b9", "title": "Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China", "authors": [{"first": "L", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "F", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "L", "middle": [], "last": "Xie", "suffix": ""}], "year": 2020, "venue": "Ann Oncol", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF10": {"ref_id": "b10", "title": "Characteristics of COVID-19 infection in Beijing", "authors": [{"first": "S", "middle": [], "last": "Tian", "suffix": ""}, {"first": "N", "middle": [], "last": "Hu", "suffix": ""}, {"first": "J", "middle": [], "last": "Lou", "suffix": ""}], "year": 2020, "venue": "The Journal of infection", "volume": "80", "issn": "", "pages": "401--406", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "The ROC Curves for CRP, WBC, and L to assess disease classification and for CEA to assess disease progression. The AUC values for CRP, WBC, 5.95%, respectively. The ROC curves 1-2 for CEA were analyzed to predict the progression of COVID-19. \"1\" is the ROC curve for CEA for disease progression from moderate to severe type, while \"2\" is the curve for disease progression from moderate to critically severe type. The AUC values of these curves were 0.578(0.442-0.715) and 0.741(0.644-0.839), respectively.", "latex": null, "type": "figure"}, "FIGREF1": {"text": "Survival curves of patients with different initial levels of CEA, WBC, L, and CRP. COVID-19 patients with initial CEA levels of over 7.75 or 29.75 ng/mL had worse outcomes than patients with lower CEA levels. Patients with L counts and L% less than 0.545 G/L and 5.95% had worse outcomes than the patients with higher L counts and L%, respectively. There was no significant difference in outcome between patients with CRP levels of over 156.5 ng/mL and patients with lower CRP levels.", "latex": null, "type": "figure"}, "FIGREF2": {"text": "Construction of nomogram with CEA and other significant indicators that predicted the probability of COVID-19 patients for overall survival. For using the nomogram, the value of individual patients with COVID-19 is located on each variable axis, and a line is depicted upward to determine the number of points received for each variable value. The sum of these numbers is located on the Total Point axis, and a line is drawn downward to the survival axes to predict the likelihood of 1-, 2-month survival of OS.", "latex": null, "type": "figure"}, "TABREF0": {"text": "The clinical characteristics of 161 patients infected with COVID-19 Note: Symbol * presents CRP level; Symbol & presents WBC count; Symbol # presents L count. Symbol @ presents moderate patients vs severe patients; Symbol $ presents severe patients vs critically severe patients; Symbol \u00a7 presents moderate patients vs critically severe patients. P<0.05 indicates that the difference was statistically significant.", "latex": null, "type": "table"}}, "back_matter": [{"text": "This study was supported by grants from the Health and Family Planning Commission Foundation of Hubei Province awarded to Lei Nie (No. WJ2019H194). We would like to thank all medical staffs fighting against COVID-19.", "cite_spans": [], "ref_spans": [], "section": "Acknowledgments"}]}